KOMZIFTI (ziftomenib) Added to National Comprehensive Cancer Network (NCCN) Guidelines for Acute Myeloid Leukemia (AML)
KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated…
BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis
The Company continues working with the third-party manufacturer to address recent FDA…
atom11 Wins the AI Innovation Award at Amazon Partner Awards 2025
URL: /atom11-wins-amazon-ads-partner-award-2025/ NASHVILLE, Tenn., Nov. 25, 2025 (GLOBE NEWSWIRE) -- At atom11,…
ACASPRESSO Announces Black Friday Mega Sale on Coffee and Blending Appliances
Zhuhai, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ACASPRESSO, an emerging brand in…
Nokia introduces MantaRay SON to NTT DOCOMOs multi-vendor 5G network
Nokia introduces MantaRay SON to NTT DOCOMO’s multi-vendor 5G network Nokia and…
Pennsylvania Perio & Implants Announces Strengthened Commitment to Evidence-Based Periodontal and Dental Implant Evaluation in Pennsylvania
York, Pennsylvania, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Pennsylvania Perio & Implants…
Junshi Biosciences Announces Primary Endpoints Met in JS001scs Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC
SHANGHAI, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd…
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Natures Signal Transduction and Targeted Therapy
Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE,…
DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meeting
November 24, 2025 02:00 ET | Source: DXS International PLC Monday 24…
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V.…
